Exact Mass: 272.0106
Exact Mass Matches: 272.0106
Found 374 metabolites which its exact mass value is equals to given mass value 272.0106
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7-ACA
7beta-aminocephalosporanic acid is the alpha,beta-unsaturated monocarboxylic acid that is the active nucleus for the synthesis of cephalosporins and intermediates. It is functionally related to a cephalosporanic acid. It is a tautomer of a 7beta-aminocephalosporanic acid zwitterion. 7-Aminocephalosporanic acid has been reported in Apis cerana D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(Z)-4-(2-Hydroxy-5-sulfonatophenyl)-2-oxo-3-butenoate
3-(Phenylsulfonyl)acrylophenone
A sulfone that is 1-phenyl-2-propenone with a phenylsulfonyl group at position 3.
2-epi-5-epi-Valiolone 7-phosphate
A member of the class of cyclitols that is 2-epi-5-epi-valiolone carrying a phospho substituent at position 7.
6,7-Dichloro-l-tryptophan
A non-proteinogenic L-alpha-amino acid that is L-tryptophan in which the hydrogens at positions 6 and 7 on the indole ring have been replaced by chlorines.
5-Epi-valiolone 7-phosphate
A member of the class of cyclitols that is 5-epi-valiolone carrying a phospho substituent at position 7.
Fukiic acid
Fukiic acid is found in green vegetables. Fukiic acid is a hydrolysis produced from Petasites japonicus (sweet coltsfoot
Zoledronate
Zoledronate (zoledronic acid, marketed by Novartis under the trade names Zometa and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronate is a single 5 mg infusion for the treatment of Pagets disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
5-(Hydroxyphenyl)-gamma-valerolactone-O-sulphate
5-(Hydroxyphenyl)-gamma-valerolactone-O-sulphate belongs to the family of Substituted Benzenes. These are aromatic compounds containing a benzene substituted at one or more positions.
5-(4'-Hydroxyphenyl)-γ-valerolactone 4'-sulfate
(+)-1-(9-Fluorenyl)ethyl chloroformate
7-Aminocephalosporanic acid
Hexose monophosphate
Dibenzo(b,f)thiepin-3-methanol, 5,5-dioxide
1,7-Dihydroxy-2,3-methylenedioxyxanthone
1,7-Dihydroxy-2,3-methylenedioxyxanthone is a natural product found in Polygala fallax, Polygala arillata, and other organisms with data available.
1,3,6,8-tetrahydroxyanthraquinone
A tetrahydroxyanthraquinonen that is 9,10-anthraquinone substituted by hydroxy groups at positions 1, 3, 6 and 8. It has been isolated from Chaetomium globosum and Leptographium wageneri.
1-acetoxy-4-(5-penta-1,3-diynyl-thiophen-2-yl)-but-3-yn-2-ol|2-Hydroxy,1-Ac-4-[5-(1,3-Pentadiynyl)-7-thienyl]-3-butyn-1-ol
(5S,6R)-5,6-dichloro-2-dichloromethyl-6-methyl-octa-1,3t,7-triene
1,6-Dihydroxy-7,8-methylendioxy-xanthon|1,6-Dihydroxy-7,8-methylendioxyxanthon
4-bromo-6,8-dihydroxy-3-methylisochroman-1-one|4-bromo-6-hydroxymellein
2-(prop-1-inyl)-5-(6-acetoxy-5-hydroxyhexa-1,3-diinyl)-thiophene
7-methanesulfonylmethyl-1,3-dimethyl-3,7-dihydro-purine-2,6-dione|alpha-<7-(1,3-Dimethylxanthinyl)>methylmethylsulfon
7-Aminocephalosporanic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Zoledronic acid
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Zoledronate
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
2,6-diamino-4-(2-fluorophenyl)-4H-thiopyran-3,5-dicarbonitrile
4,5-dichloro-2-(2-fluorobenzyl)pyridazine-3(2h)-one
2-Propenoic acid,3-(3-bromo-4-hydroxy-5-methoxyphenyl)-
Butanoic acid,4-[[4-(aminosulfonyl)phenyl]amino]-4-oxo-
Nitroscanate
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]benzaldehyde
ETHYL 4-HYDROXY-3-(METHYLTHIO)-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBOXYLATE
4-CHLORO-2-CHLOROMETHYL-5,6,7,8-TETRAHYDRO-BENZO[4,5]THIENO[2,3-D]PYRIMIDINE
2-[(2-chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
3-(4-Fluorophenyl)-2-thioxo-2,3-dihydro-4(1H)-quinazolinone
Z-2-(2,3-Dichlorophenyl)methylene-3-oxobutanoic acid methyleater
(1S,4S)-2-(3-fluorophenyl)-2,5-diazabicyclo[2.2.1]heptane,hydrobromide
N-METHYL-N-([2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-4-YL]METHYL)AMINE
(7-BROMO-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)(2-METHOXYPHENYL)METHANONE
(6-BROMO-2-PYRIDINYL)-CARBAMICACID,1,1-DIMETHYLETHYLESTER
Sulfadiazine sodium
C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent
6-(4-bromopiperidin-1-yl)-1,3,5-triazine-2,4-diamine
2-(3,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-(2-Amino-5-chlorophenyl)-1H-isoindole-1,3(2H)-dione
2,6-diamino-4-(4-fluorophenyl)-4H-thiopyran-3,5-dicarbonitrile
Tricyclo[3.3.1.13,7]decane-1-carboxylicacid, 3-bromo-5-methyl-
2-BENZO[1,3]DIOXOL-5-YL-6-CHLORO-IMIDAZO[1,2-A]PYRIDINE
1-(CHLOROMETHYL)-4-(METHYLSULFONYL)-2-(TRIFLUOROMETHYL)BENZENE
2-(3,5-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
5-tert-butoxycarbonylamino-2-chloro-nicotinic acid
4,4-BIS(METHYLTHIO)-2-PHENYL-1,3-BUTADIEN-1,1-DICARBONITRILE
sodium [(6-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetate
3-(4-CHLORO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-8-CARBOXYLIC ACID
(S)-1-Bromo-4-((3-methoxy-2-methylpropoxy)methyl)benzene
1,3-Butanedione,1-benzo[b]thien-3-yl-4,4,4-trifluoro-
4-Chloro-2-(chloromethyl)-6,7-dimethoxyquinazoline
(1S,4S)-(-)-2-(4-FLUOROPHENYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE, HYDROBROMIDE
4-phenyl-5-(trifluoromethyl)-2-thiophenecarboxylic acid
4-(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid
3-(4-fluorophenoxy)-7-hydroxy-4h-1-benzopyran-4-on
(2-BROMO-PYRIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER
(5-BROMO-2-METHOXY-PHENYL)-ACETIC ACID ETHYL ESTER
3-[(5-Bromo-pyridine-3-carbonyl)-amino]-propionic acid
2-(2-HYDROXYETHYLAMINO)-N-(3-BROMOPHENYL)ACETAMIDE
5-[4-(Trifluoromethoxy)phenyl]furan-2-carboxylic Acid
1,3-dihydro-imidazol-2-one-5-(4-trifluoromethyl)phenyl-4-carboxylic acid
5-(4-METHOXYPHENYL)PYRIDIN-2-YLAMINE DIHYDROCHLORIDE
2H-Pyrido[1,2-a]-1,3,5-triazine-2,4(3H)-dithione,3-(2-pyridinyl)-
N-ISOBUTYL-N-[(1-METHYL-1H-PYRAZOL-4-YL)METHYL]-AMINE
7-BROMO-6-FLUORO-3,3-DIMETHYL-3,4-DIHYDROQUINOXALIN-2(1H)-ONE
6,8-DICHLORO-2H-CHROMENE-3-CARBOXYLIC ACID ETHYL ESTER
5-[(tert-butoxycarbonyl)amino]-2-chloroisonicotinic acid
1-(3-(TRIFLUOROMETHOXY)PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID
6-Methyl-2(propane-1-sulfonyl)-2H-thieno[3,2-D][1,2,3]diazaborinin-1-OL
Methanone, (4-chloro-5-hydroxy-3-benzofuranyl)phenyl-
3-(difluoromethoxy)-N-(4,5-dihydrothiazol-2-yl)benzamide
N-(3,4-Dichlorophenyl)-2-oxopyrrolidine-1-carboxamide
2-(2-Chloropyridin-4-Yl)-4-Methyl-1h-Isoindole-1,3(2h)-Dione
(6R)-3-(acetoxymethyl)-7-ammonio-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(2S)-2-azaniumyl-3-(6,7-dichloro-1H-indol-3-yl)propanoate
(2R,4R,5S,6R)-4,5-dihydroxy-6-(phosphonooxymethyl)oxane-2-carboxylic acid
(2S,4R,5S,6R)-4,5-dihydroxy-6-(phosphonooxymethyl)oxane-2-carboxylic acid
2-(4,5,6,7-Tetrahydrothieno[2,3-c]pyridin-3-yl)-1,3-benzothiazole
2-[(2,4-Dichlorophenyl)methylthio]-1-methylimidazole
(E)-2-(4-fluorostyryl)-5-(thiophen-2-yl)-1,3,4-oxadiazole
(E)-1-[5-(2-Chlorophenyl)furan-2-yl]-N-(1,2,4-triazol-4-yl)methanimine
(7R)-3-(acetyloxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(7-Hydroxy-1-oxoisochromen-3-yl)methyl hydrogen sulate
[2-methoxy-4-[(E)-3-oxobut-1-enyl]phenyl] hydrogen sulfate
6-(2,3-dichlorophenyl)-2-oxo-1H-1,2,4-triazin-2-ium-3,5-diamine
(5-Hydroxy-2-methylchromen-2-yl)methyl hydrogen sulate
1-(4-Methoxy-1-benzouran-5-yl)ethyl hydrogen sulate
(Z)-4-(2-hydroxy-5-sulfo-phenyl)-2-oxo-but-3-enoic Acid
7beta-aminocephalosporanic acid zwitterion
Zwitterionic form of 7beta-aminocephalosporanic acid.
7beta-aminocephalosporanic acid
The alpha,beta-unsaturated monocarboxylic acid that is the active nucleus for the synthesis of cephalosporins and intermediates.
adefovir(1-)
A organophosphonate oxoanion obtained by removal of a proton from the phosphonate group of adefovir, a nucleoside reverse transcriptase inhibitor. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
6,7-dichloro-L-tryptophan zwitterion
An L-alpha-amino acid zwitterion resulting from the transfer of a proton from the carboxy group to the alpha-amino group of 6,7-dichloro-L-tryptophan; major species at pH 7.3.
2-Methylcitric acid (trisodium)
2-Methylcitric acid trisodium (Methylcitric acid trisodium) is an endogenous metabolite in the 2-methylcitric acid cycle. 2-Methylcitric acid trisodium accumulates in methylmalonic and propionic acidemias and acts as a marker metabolite. 2-Methylcitric acid trisodium markedly inhibits ADP-stimulated and uncoupled respiration in mitochondria supported by glutamate[1].